PCVX

Vaxcyte, Inc.

Healthcare · USD

Set alert

Price alert · PCVX

All alert types
62.03 USD -0.58 -0.93%
As of Oct 30, 2026 Extended hours 61.99 -0.06%
Bid
61.95 × 2
Ask
62.03 × 2
61.02 Day range 63.28
40.32 52-week range 73.82
YTD
+34.44%
1 year
+38.61%
Open
62.59
Prev close
62.61
Mkt cap
9.76B
Vol
1.71M
Avg vol
2.06M
EPS
-7.62
P/E
0.00
Div yield
0.00%
More statistics
Low
61.02
High
63.28
Forward P/E
-8.71
Beta
1.23
Short ratio
4.40
Inst. own
111.05%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
61.59
200-d avg
56.97
1y target
117.30

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for PCVX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

13.53 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -8.2×
FY 2017: -5.4×FY 2018: -3.2×FY 2019: -1.9×FY 2020: -8.9×FY 2021: -12.3×FY 2022: -13.9×FY 2023: -15.2×FY 2024: -21.5×FY 2025: -8.2×
FY 2017 5y median -13.9× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 2.3×
FY 2017: 3.0×FY 2018: -1.6×FY 2019: -0.9×FY 2020: 2.3×FY 2021: 4.3×FY 2022: 3.3×FY 2023: 4.9×FY 2024: 3.0×FY 2025: 2.3×
FY 2017 5y median 3.3× FY 2025
P/FCF -9.4×
FY 2017: -5760×FY 2018: -2.9×FY 2019: -2.1×FY 2020: -16.4×FY 2021: -9.7×FY 2022: -17.6×FY 2023: -16.7×FY 2024: -21.0×FY 2025: -9.4×
FY 2017 5y median -16.7× FY 2025
EV/EBITDA -8.5×
FY 2017: -3.6×FY 2018: -1.0×FY 2019: -0.8×FY 2020: -4.5×FY 2021: -12.2×FY 2022: -10.7×FY 2023: -14.6×FY 2024: -21.6×FY 2025: -8.5×
FY 2017 5y median -12.2× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -10.7%
FY 2017: -0.0%FY 2018: -34.0%FY 2019: -48.7%FY 2020: -6.1%FY 2021: -10.4%FY 2022: -5.7%FY 2023: -6.0%FY 2024: -4.8%FY 2025: -10.7%
FY 2017 5y median -6.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -28.5%
FY 2017: -55.7%FY 2018: 51.1%FY 2019: 47.3%FY 2020: -25.8%FY 2021: -35.2%FY 2022: -23.4%FY 2023: -32.4%FY 2024: -14.0%FY 2025: -28.5%
FY 2017 5y median -28.5% FY 2025
ROIC -32.5%
FY 2017: -50.0%FY 2018: -55.2%FY 2019: -98.8%FY 2020: -25.9%FY 2021: -34.5%FY 2022: -23.9%FY 2023: -36.9%FY 2024: -16.9%FY 2025: -32.5%
FY 2017 5y median -32.5% FY 2025
ROA -25.2%
FY 2017: -43.5%FY 2018: -41.6%FY 2019: -76.5%FY 2020: -22.7%FY 2021: -30.9%FY 2022: -22.2%FY 2023: -28.6%FY 2024: -13.2%FY 2025: -25.2%
FY 2017 5y median -25.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -62.2%
FY 2017: 0.0%FY 2018: -99.3%FY 2019: -52.4%FY 2020: -65.4%FY 2021: -15.7%FY 2022: -124.0%FY 2023: -101.5%FY 2024: -21.7%FY 2025: -62.2%
FY 2017 FY 2025
EPS (diluted) -48.2%
FY 2017: 0.0%FY 2018: -68.1%FY 2019: -73.6%FY 2020: 78.9%FY 2021: 35.0%FY 2022: -78.2%FY 2023: -20.3%FY 2024: 8.2%FY 2025: -48.2%
FY 2017 FY 2025
Free Cash Flow -40.9%
FY 2017: 0.0%FY 2018: -199096.8%FY 2019: -49.9%FY 2020: 1.2%FY 2021: -167.8%FY 2022: -37.9%FY 2023: -106.7%FY 2024: -30.3%FY 2025: -40.9%
FY 2017 FY 2025

Financial Health

Current Ratio 7.9×
FY 2017: 8.5×FY 2018: 9.9×FY 2019: 5.6×FY 2020: 8.3×FY 2021: 8.9×FY 2022: 23.3×FY 2023: 7.5×FY 2024: 12.8×FY 2025: 7.9×
FY 2017 5y median 8.9× FY 2025
Quick Ratio 7.9×
FY 2017: 8.5×FY 2018: 9.9×FY 2019: 5.6×FY 2020: 8.3×FY 2021: 8.9×FY 2022: 23.3×FY 2023: 7.5×FY 2024: 12.8×FY 2025: 7.9×
FY 2017 5y median 8.9× FY 2025
Debt / Equity 0.1×
FY 2017: 0.1×FY 2018: -0.0×FY 2019: -0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.1×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA -0.1×
FY 2017: 1.8×FY 2018: 2.3×FY 2019: 1.2×FY 2020: 4.4×FY 2021: 0.5×FY 2022: 3.8×FY 2023: 0.9×FY 2024: 0.7×FY 2025: -0.1×
FY 2017 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: -474×FY 2019: -1354×FY 2020: -12797×FY 2021: -14810×FY 2022: -116128×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31